Pirozadil
CAS No. 54110-25-7
Pirozadil( —— )
Catalog No. M19963 CAS No. 54110-25-7
Pirozadil is a hypolipidemic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePirozadil
-
NoteResearch use only, not for human use.
-
Brief DescriptionPirozadil is a hypolipidemic agent.
-
DescriptionPirozadil is a hypolipidemic agent.
-
In Vitro——
-
In VivoPirozadil is a hypolipidemic agent. Pirozadil's effect on increasing cerebral blood flow is almost equal to that of papaverine, less than that of nicardipine and much greater than that of the other hypolipidemic/ antiatherogenic drugs, nicotinic acid and pyridinol carbamate. Pirozadil is also shown to significantly diminish vascular cerebral resistance to a much greater degree than nicotinic acid and pyridinol carbamate.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number54110-25-7
-
Formula Weight527.52
-
Molecular FormulaC27H29NO10
-
Purity>98% (HPLC)
-
SolubilityDMSO: 60 mg/mL need ultrasonic;Water: Insoluble
-
SMILESCOc1cc(cc(OC)c1OC)C(=O)OCc1cccc(COC(=O)c2cc(OC)c(OC)c(OC)c2)n1
-
Chemical Name26-Pyridinediyldimethylene-bis(345-trimethoxybenzoate)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
GANODERIC ACID C2(SH...
(Rac)-Ganoderic acid C2 is the racemate of Ganoderic acid C2 . Ganoderic acid C2 is a bioactive triterpenoid in Ganoderma lucidum. Ganoderic acid C2 possesses anti-tumor, antihistamine, anti-aging and cytotoxic effects. Ganoderic acid C2 exhibits high inhibitory activity against the rat lens aldose reductase (RLAR) with an IC50 of 3.8 μM.
-
TP0586532
TP0586532 is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk.
-
Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
Cart
sales@molnova.com